Cargando…
Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease
Autores principales: | Floch, Aline, Morel, Alexandre, Zanchetta-Balint, Fabian, Cordonnier-Jourdin, Catherine, Allali, Slimane, Grall, Maximilien, Ithier, Ghislaine, Carpentier, Benjamin, Pakdaman, Sadaf, Merle, Jean-Claude, Goulabchand, Radjiv, Khalifeh, Tackwa, Berceanu, Ana, Helmer, Cécile, Chantalat-Auger, Christelle, Frémeaux-Bacchi, Véronique, Michel, Marc, de Montalembert, Mariane, Mekontso-Dessap, Armand, Pirenne, France, Habibi, Anoosha, Bartolucci, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604638/ https://www.ncbi.nlm.nih.gov/pubmed/33131265 http://dx.doi.org/10.3324/haematol.2020.253856 |
Ejemplares similares
-
Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysis
por: Lopinto, Julien, et al.
Publicado: (2022) -
What if the worst consequences of COVID-19 concerned non-COVID patients?
por: Goulabchand, Radjiv, et al.
Publicado: (2020) -
Chronic organ injuries in children with sickle cell disease
por: Allali, Slimane, et al.
Publicado: (2021) -
Innate immune cells, major protagonists of sickle cell disease pathophysiology
por: Allali, Slimane, et al.
Publicado: (2020) -
Digital tablets to improve quality of life of COVID-19 older inpatients during lockdown
por: Goulabchand, Radjiv, et al.
Publicado: (2020)